Syros Pharmaceuticals, Inc. (NASDAQ:SYRS)
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) represented a move of 0 percent or $0.42 per share and closed its previous day trading session at $7. 0 Shares were traded in the last trading session with an Average Volume of 123.74 Million Shares. The stock currently has a Market Capitalization of 243.18 Million.
Syros Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on treatments for cancer and immune-mediated diseases as well as building a pipeline of gene control medicines. The company’s product pipeline includes SY-1425, a selective RARa agonist for genomically defined subsets of patients with relapsed or refractory acute myeloid leukemia and relapsed high-risk myelodysplastic syndrome and SY-1365, a selective CDK7 inhibitor for acute leukemia which is in preclinical stage. Syros Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.
The stock traded between $ 6.25 and $14.90 over 1-Year time period showing its price to sales ratio of 202.65. Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-13.89 and 200-Day Simple Moving Average of $-36.33. Its Price to Free Cash Flow is 0 and Price to Book of 2.48.
Analyst’s recommended the stock as 1.9 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) reported its Actual EPS of $-0.47/share. The analysts offering Earnings Estimates for the company were believing that Syros Pharmaceuticals, Inc. could bring EPS of $-0.46/share. The difference between Actual EPS and Estimated EPS was -0.01 Percent. Thus showing an Earnings Surprise of -2.2 Percent.
Medley Management Inc. (NYSE:MDLY)
In the last trading session, Medley Management Inc. (NYSE:MDLY) added its value by 0% closing at the price of $5.12. The stock currently has market capitalization of 159.23 Million, with average volume of 27.46 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Medley Management Inc. (NYSE:MDLY) is showing beta of 1.3. This particular value of beta suggests that Medley Management Inc. (NYSE:MDLY) has historically moved 130% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Medley Management Inc. (NYSE:MDLY) is at $-0.77.
The stock currently has RSI of 39.97. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Medley Management Inc. is an asset management firm. It engages in providing institutional and retail investors with yield-oriented investment products that pay periodic dividends or distributions. The Company focuses on credit-related investment strategies, primarily originating senior secured loans to private middle market companies in the United States. Medley Management Inc. is based in New York.
Medley Management Inc. (NYSE:MDLY) topped its 52-week high price of $7.15 on 12/21/17 and 52-Week Low Price of $3.10 on 06/15/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 3.21% and monthly volatility of 3.03% respectively.